Stock listing
LNTH Stock Price, News, Filings & Events — Lantheus Holdings, Inc.
Selected listing: LNTH · BX · CHF · CH
This page tracks Lantheus Holdings, Inc.'s LNTH:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LNTH:BX. LNTH:BX is the stock-level entry point for investors researching Lantheus Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Lantheus Holdings, Inc. (ticker: LNTH) is a public company operating in the American market, with a market capitalization of approximately $6.82 billion. The company focuses on developing and commercializing innovative diagnostic and therapeutic products. Lantheus is committed to improving patient care through advanced medical imaging and targeted therapies.
- Ticker
- LNTH:BX
- Asset type
- Stock
- Market cap
- $6.58B
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- BX
- Currency
- CHF
Lantheus Holdings, Inc. LNTH:BX stock context
This page tracks Lantheus Holdings, Inc.'s LNTH:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LNTH:BX. LNTH:BX is the stock-level entry point for investors researching Lantheus Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Lantheus Holdings, Inc. (ticker: LNTH) is a public company operating in the American market, with a market capitalization of approximately $6.82 billion. The company focuses on developing and commercializing innovative diagnostic and therapeutic products. Lantheus is committed to improving patient care through advanced medical imaging and targeted therapies.
Latest news from Lantheus Holdings, Inc.
Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease
August 14, 2026
Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings...
August 7, 2026
Lantheus to Host Second Quarter 2026 Earnings Conference Call and Webcast on August 6, 2026, at 8:00 a.m. Eastern Time
July 23, 2026
Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide)
June 26, 2026
Lantheus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
June 3, 2026
Lantheus Holdings, Inc. earnings calls
Lantheus Holdings, Inc. (LNTH) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Lantheus Holdings, Inc. (LNTH) Q4 2025 Earnings Call
February 26, 2026 · Replay with transcript and chapters
Lantheus Holdings, Inc. (LNTH) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Lantheus Holdings, Inc. (LNTH) Q2 2025 Earnings Call
August 6, 2025 · Replay with transcript and chapters
Lantheus Holdings, Inc. (LNTH) Q1 2025 Earnings Call
May 7, 2025 · Replay with transcript and chapters
Lantheus Holdings, Inc. (LNTH) Q4 2024 Earnings Call
February 26, 2025 · Replay with transcript and chapters
Research Lantheus Holdings, Inc.
Lantheus Holdings, Inc. investor report
Review AI stock analysis and investor report context for LNTH:BX.
Lantheus Holdings, Inc. company profile
View the public company page for Lantheus Holdings, Inc. on 6ix.
Lantheus Holdings, Inc. news
Read company news and market updates connected to Lantheus Holdings, Inc..
Lantheus Holdings, Inc. investor events
Find investor webinars, events, and replay context for Lantheus Holdings, Inc..
Alternate listings
LNTH:NASDAQ
US · USD
Alternate listing for Lantheus Holdings, Inc.; the primary context on this page is LNTH:BX.
0L8:GETTEX
DE · EUR
Alternate listing for Lantheus Holdings, Inc.; the primary context on this page is LNTH:BX.
0L8:TRADEGATE
DE · EUR
Alternate listing for Lantheus Holdings, Inc.; the primary context on this page is LNTH:BX.
A117UE:LSX
DE · EUR
Alternate listing for Lantheus Holdings, Inc.; the primary context on this page is LNTH:BX.
0L8:FWB
DE · EUR
Alternate listing for Lantheus Holdings, Inc.; the primary context on this page is LNTH:BX.
A117UE:LS
DE · EUR
Alternate listing for Lantheus Holdings, Inc.; the primary context on this page is LNTH:BX.
1LNTH:MIL
IT · EUR
Alternate listing for Lantheus Holdings, Inc.; the primary context on this page is LNTH:BX.
LNTH:BOATS
US · USD
Alternate listing for Lantheus Holdings, Inc.; the primary context on this page is LNTH:BX.
0L8:DUS
DE · EUR
Alternate listing for Lantheus Holdings, Inc.; the primary context on this page is LNTH:BX.
0L8:HAM
DE · EUR
Alternate listing for Lantheus Holdings, Inc.; the primary context on this page is LNTH:BX.
0L8:MUN
DE · EUR
Alternate listing for Lantheus Holdings, Inc.; the primary context on this page is LNTH:BX.
0L8:SWB
DE · EUR
Alternate listing for Lantheus Holdings, Inc.; the primary context on this page is LNTH:BX.